Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma

被引:0
作者
Amanda Lassen
Mohammad Atefi
Lidia Robert
Deborah JL Wong
Michael Cerniglia
Begonya Comin-Anduix
Antoni Ribas
机构
[1] University of California Los Angeles (UCLA),Department of Medicine, Division of Hematology
[2] University of California Los Angeles (UCLA),Oncology, David Geffen School of Medicine
[3] University of California Los Angeles (UCLA),Department of Surgery, Division of Surgical Oncology, David Geffen School of Medicine
[4] Jonsson Comprehensive Cancer Center (JCCC),Department of Molecular and Medical Pharmacology, David Geffen School of Medicine
[5] UCLA,Department of Medicine, Division of Hematology
[6] Jonsson Comprehensive Cancer Center at UCLA,Oncology, 11
来源
Molecular Cancer | / 13卷
关键词
Melanoma; AKT inhibitor; Dabrafenib; Combination therapy; Drug resistance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 581 条
  • [41] Su F(2014)MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition Cancer Discov 4 61-undefined
  • [42] Higgins B(undefined)undefined undefined undefined undefined-undefined
  • [43] Iyer R(undefined)undefined undefined undefined undefined-undefined
  • [44] D'Andrea K(undefined)undefined undefined undefined undefined-undefined
  • [45] Koehler A(undefined)undefined undefined undefined undefined-undefined
  • [46] Stumm M(undefined)undefined undefined undefined undefined-undefined
  • [47] Lin PS(undefined)undefined undefined undefined undefined-undefined
  • [48] Lee RJ(undefined)undefined undefined undefined undefined-undefined
  • [49] Grippo J(undefined)undefined undefined undefined undefined-undefined
  • [50] Hauschild A(undefined)undefined undefined undefined undefined-undefined